Search research articles
Contact Us
Filters
Showing results (201-210 of 435) with videos related to
Page
of 44
Sort By:
Annals of the Rheumatic Diseases
|
March 11, 2016
The changing landscape of biosimilars in rheumatology
Thomas Dörner, Vibeke Strand, Paul Cornes, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
June 15, 2017
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review
Vibeke Strand, Alejandro Balsa, Jamal Al-Saleh, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2004
Lefunomide in combination therapy
Joachim R Kalden, Josef S Smolen, Paul Emery, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2004
The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy
Josef S Smolen, Paul Emery, Joachim R Kalden, et al.
Current Medical Research and Opinion
|
May 26, 2021
Immune-mediated diseases and thromboembolic events: a modified Delphi panel
Nassir Azimi, Freddy Caldera, Stan Cohen, et al.
The Journal of Rheumatology
|
January 14, 2004
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)
Daniel E Furst, Michael H Schiff, Roy M Fleischmann, et al.
The Lancet. Rheumatology
|
May 5, 2025
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial
Vibeke Strand, Kenneth C Kalunian, Kai Wai Lee, et al.
Rheumatology and Therapy
|
November 10, 2023
Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis
Jeffrey R Curtis, Vibeke Strand, Steven J Golombek, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2004
Leflunomide: a manageable safety profile
Peit L C M van Riel, Josef S Smolen, Paul Emery, et al.
The Lancet. Rheumatology
|
July 23, 2025
Reassessing antimalarial use in long-term SLE clinical trials - Authors' reply
Vibeke Strand, Kenneth C Kalunian, Kai Wai Lee, et al.
Page
of 44
Search research articles
Search
Showing results (201-210 of 435) with videos related to
Sort By:
Page
of 44
Annals of the Rheumatic Diseases
|
March 11, 2016
The changing landscape of biosimilars in rheumatology
Thomas Dörner, Vibeke Strand, Paul Cornes, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
June 15, 2017
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review
Vibeke Strand, Alejandro Balsa, Jamal Al-Saleh, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2004
Lefunomide in combination therapy
Joachim R Kalden, Josef S Smolen, Paul Emery, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2004
The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy
Josef S Smolen, Paul Emery, Joachim R Kalden, et al.
Current Medical Research and Opinion
|
May 26, 2021
Immune-mediated diseases and thromboembolic events: a modified Delphi panel
Nassir Azimi, Freddy Caldera, Stan Cohen, et al.
The Journal of Rheumatology
|
January 14, 2004
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)
Daniel E Furst, Michael H Schiff, Roy M Fleischmann, et al.
The Lancet. Rheumatology
|
May 5, 2025
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial
Vibeke Strand, Kenneth C Kalunian, Kai Wai Lee, et al.
Rheumatology and Therapy
|
November 10, 2023
Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis
Jeffrey R Curtis, Vibeke Strand, Steven J Golombek, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2004
Leflunomide: a manageable safety profile
Peit L C M van Riel, Josef S Smolen, Paul Emery, et al.
The Lancet. Rheumatology
|
July 23, 2025
Reassessing antimalarial use in long-term SLE clinical trials - Authors' reply
Vibeke Strand, Kenneth C Kalunian, Kai Wai Lee, et al.
Page
of 44